Validating blood microsampling for per- and polyfluoroalkyl substances quantification in whole blood
10.1016/j.chroma.2023.464522 · doi-reference
Development and validation of the UHPLC-MS/MS method for the quantitative determination of 25 PFAS in dried blood spots
10.1007/s00216-024-05484-6 · doi-reference
Trace analysis of per- and polyfluorinated alkyl substances (PFAS) in dried blood spots – demonstration of reproducibility and comparability to venous blood samples
10.1016/j.scitotenv.2023.163530 · doi-reference
Analysis of perfluoroalkyl substances in cord blood by turbulent flow chromatography coupled to tandem mass spectrometry
10.1016/j.scitotenv.2012.05.080 · doi-reference
An analytical method for the determination of perfluorinated compounds in whole blood using acetonitrile and solid phase extraction methods
10.1016/j.chroma.2009.04.070 · doi-reference
Development of a solid-phase extraction-HPLC/single quadrupole MS method for quantification of perfluorochemicals in whole blood
10.1021/ac049023c · doi-reference
Direct analysis of per- and polyfluoroalkyl substances (PFAS) in plasma by liquid chromatography coupled to mass spectrometry (LC–MS) for biomonitoring purposes
10.1007/s12403-026-00763-2 · doi-reference
Sensitive and accurate determination of 32 PFAS in human serum using online SPE-UHPLC-HRMS
10.1016/j.jhazmat.2024.136780 · doi-reference
Simultaneous determination of perfluoroalkyl substances and bile acids in human serum using ultra-high-performance liquid chromatography–tandem mass spectrometry
10.1007/s00216-019-02263-6 · doi-reference
Comparison of extraction methods for per- and polyfluoroalkyl substances (PFAS) in human serum and placenta samples—insights into extractable organic fluorine (EOF)
10.1007/s00216-020-03041-5 · doi-reference
Development and validation of an LC–MS/MS method for the quantitation of 30 legacy and emerging per- and polyfluoroalkyl substances (PFASs) in human plasma, including HFPO-DA, DONA, and cC6O4
10.1007/s00216-021-03762-1 · doi-reference
Evaluation and validation of methodologies for the extraction of per- and polyfluoroalkyl substances (PFASs) in serum of birds and mammals
10.1007/s00216-022-03962-3 · doi-reference
A simple and rapid method for quantitative HPLC MS/MS determination of selected perfluorocarboxylic acids and perfluorosulfonates in Human serum
10.1155/2020/8878618 · doi-reference
Blood serum concentrations of perfluorinated compounds in men from Greenlandic Inuit and European populations
10.1016/j.chemosphere.2012.03.049 · doi-reference
Analysis of perfluoroalkyl and polyfluoroalkyl substances in serum and plasma by solvent precipitation-isotope dilution-direct injection-LC/MS/MS
10.1039/c6ay02809h · doi-reference
Branched perfluorooctane sulfonate isomer quantification and characterization in blood serum samples by HPLC/ESI-MS(/MS)
10.1021/es901261v · doi-reference
Development of an LC-MS/MS method for the simultaneous quantification of 11 perfluoroalkyl compounds in mouse plasma for toxicokinetic applications
10.1016/j.jpba.2024.116596 · doi-reference
PFAS ghosts: how to identify, evaluate, and exorcise new and existing analytical interference
10.1007/s00216-024-05125-y · doi-reference
Analytical method interferences for perfluoropentanoic acid (PFPeA) and perfluorobutanoic acid (PFBA) in biological and environmental samples
10.1016/j.chemosphere.2022.137722 · doi-reference
Per- and polyfluoroalkyl substances (PFAS) exposure in the U.S. population: NHANES 1999–March 2020
10.1016/j.envres.2025.120916 · doi-reference
Serum concentrations of legacy, alternative, and precursor per- and polyfluoroalkyl substances: a descriptive analysis of adult female participants in the MIREC-ENDO study
10.1186/s12940-024-01085-z · doi-reference
Red analytical performance index (RAPI) and software: the missing tool for assessing methods in terms of analytical performance
10.1039/d4gc05298f · doi-reference
Blue applicability grade index (BAGI) and software: a new tool for the evaluation of method practicality
10.1039/d3gc02347h · doi-reference
Gestational exposure to organophosphate pesticides and maternal urine metabolomic profile in the GENEIDA birth cohort
10.1016/j.etap.2025.104793 · doi-reference
Human biomonitoring of persistent and non-persistent pollutants in a representative sample of the general population from Cape Verde: results from the PERVEMAC-II study
10.1016/j.envpol.2022.119331 · doi-reference
A rapid and simple method to quantify per- and polyfluoroalkyl substances (PFAS) in plasma and serum using 96-well plates
10.1016/j.mex.2020.101111 · doi-reference
Perfluoroalkyl and polyfluoroalkyl substances in cord blood of newborns in Shanghai, China: implications for risk assessment
10.1016/j.envint.2016.10.008 · doi-reference
Analysis of perfluorinated chemicals in umbilical cord blood by ultra-high performance liquid chromatography/tandem mass spectrometry
10.1016/j.jchromb.2011.01.037 · doi-reference
Temporal trends of perfluoroalkyl acids in plasma samples of pregnant women in Hokkaido, Japan, 2003-2011
10.1016/j.envint.2013.07.013 · doi-reference
Refined SPE–LC–MS/MS method for simultaneous quantification of legacy PFAS in Korean population serum under volume-limited conditions
10.1016/j.jchromb.2026.125096 · doi-reference
Poly- and perfluoroalkyl substances in maternal serum: method development and application in Pilot Study of the Japan Environment and Children’s Study
10.1016/j.chroma.2020.460933 · doi-reference
Associations between concentrations of perfluoroalkyl substances in human plasma and maternal, infant, and home characteristics in Winnipeg, Canada
10.1016/j.envpol.2019.03.054 · doi-reference
Distribution of novel and well-known poly- and perfluoroalkyl substances (PFASs) in Human serum, plasma, and whole blood
10.1021/acs.est.7b03299 · doi-reference
Comparison of human whole blood, plasma, and serum matrices for the determination of perfluorooctanesulfonate (PFOS), perfluorooctanoate (PFOA), and other fluorochemicals
10.1016/j.envres.2006.06.008 · doi-reference
Partition of perfluoroalkyl substances (PFASs) in whole blood and plasma, assessed in maternal and umbilical cord samples from inhabitants of arctic Russia and Uzbekistan
10.1016/j.scitotenv.2013.01.029 · doi-reference
Self-collection blood test for PFASs: comparing volumetric microsamplers with a traditional serum approach
10.1021/acs.est.2c09852 · doi-reference
Techniques to characterize PFAS burden in biological samples: recent insights and remaining challenges
10.1016/j.teac.2023.e00224 · doi-reference
A sensitive and robust method for the simultaneous determination of thirty-three legacy and emerging per- and polyfluoroalkyl substances in human plasma and serum
10.1007/s00216-022-04426-4 · doi-reference
Analytical methods employed in the identification and quantification of per- and polyfluoroalkyl substances in human matrices - A scoping review
10.1016/j.chemosphere.2023.140433 · doi-reference
Perfluorooctanoic acid (PFOA)-main concerns and regulatory developments in Europe from an environmental point of view
10.1186/2190-4715-24-16 · doi-reference
